These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prognostic value of anti-cytomegalovirus IgM in kidney graft recipients. Tardy JC; Pouteil-Noble C; Touraine JL; Aymard M Transplant Proc; 1987 Oct; 19(5):4066-7. PubMed ID: 2823432 [No Abstract] [Full Text] [Related]
7. Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials. Snydman DR; Werner BG; Tilney NL; Kirkman RL; Milford EL; Cho SI; Bush HL; Levey AS; Strom TB; Carpenter CB Transplant Proc; 1991 Feb; 23(1 Pt 2):1357-60. PubMed ID: 1846464 [No Abstract] [Full Text] [Related]
8. Results of prospective matching for cytomegalovirus status in renal transplant recipients. Ludwin D; White N; Tsai S; Chernesky M; Achong M; Smith EK Transplant Proc; 1987 Aug; 19(4):3433-4. PubMed ID: 3039700 [No Abstract] [Full Text] [Related]
9. Cytomegalovirus antibodies in renal transplant recipients. Jankowski M; Gut W; Nawrocka E; Gradowska L; Roncewicz Z; Rowińska D Acta Microbiol Pol; 1982; 31(3-4):279-85. PubMed ID: 6189377 [TBL] [Abstract][Full Text] [Related]
10. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques. Jankowski M; Styczyński P Arch Immunol Ther Exp (Warsz); 1987; 35(3):313-9. PubMed ID: 2833198 [TBL] [Abstract][Full Text] [Related]
12. Detection of cytomegalovirus infection in renal transplant recipients in Korea. Kahng KW; Kang CM; Kwak JY Transplant Proc; 1996 Jun; 28(3):1507. PubMed ID: 8658762 [No Abstract] [Full Text] [Related]
13. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease]. Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888 [TBL] [Abstract][Full Text] [Related]
14. Use of intravenous immunoglobulin prophylaxis for primary cytomegalovirus infection post living-related-donor renal transplantation. Steinmuller DR; Graneto D; Swift C; Novick AC; Streem SB; Cunningham RJ; Hodge E; Bretan P Transplant Proc; 1989 Feb; 21(1 Pt 2):2069-71. PubMed ID: 2540554 [No Abstract] [Full Text] [Related]
15. No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group. Ruutu T; Ljungman P; Brinch L; Lenhoff S; Lönnqvist B; Ringdén O; Ruutu P; Volin L; Albrechtsen D; Sallerfors B; Ebeling F; Myllylä G Bone Marrow Transplant; 1997 Feb; 19(3):233-6. PubMed ID: 9028551 [TBL] [Abstract][Full Text] [Related]
16. Detection of the cytomegalovirus by the polymerase chain reaction DNA amplification in a kidney transplanted patient. Ergazaki M; Liloglou T; Koffa M; Kostakis A; Haliassos A; Spandidos DA In Vivo; 1993; 7(6A):531-4. PubMed ID: 8193272 [TBL] [Abstract][Full Text] [Related]